Business Wire

Intersolar Europe: Agrivoltaics – Harvesting Solar Power

Share

The world population is growing, as is the demand for food. To tackle the climate crisis, the world needs both agricultural land and surfaces for the deployment of photovoltaics (PV). In line with the zeitgeist, agricultural PV brings together both worlds: agriculture and renewable power generation. Solar modules built over fields can transport us into the new energy world faster, all the while protecting important agricultural yields. This is why Intersolar Europe – The world’s leading exhibition for the solar industry – will be focusing on the topic. Together with the French-German Office for Energy Transition (DFBEW), Intersolar Europe will be presenting new business models and best practices from France and Germany. Agricultural PV is also on the agenda of the Intersolar Europe Conference. Intersolar Europe will be held as part of The smarter E Europe, the continent’s largest platform for the energy industry, from June 14 to 16, 2023 in Munich.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230427005413/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Trend topic Agrivoltaics will be presented at Intersolar Europe 2023 in Munich, Germany. (Photo: Solar Promotion GmbH)

Agrivoltaics is currently trending. Agrivoltaics projects are demonstrating how the generation of solar power and agriculture can go hand in hand and benefit from each other and how the conflict over available surfaces can be cleverly solved.

Renewable electricity for decentralized self-consumption is a great opportunity for agricultural operations adding solar installations to their assets. It allows them to use the renewable power generated on their land and reduce their bills for grid-supplied electricity. If they have excess electricity, they can sell it, which provides an additional source of income. What’s more, agricultural PV installations can boost resilience and increase the yield of agricultural operations because solar modules offer protection against heavy rain, hail or drought for fruit and special crops.

Europe recognizes potential

In many European countries, more and more farmers and political decision-makers are recognizing the potential of agricultural PV. Italy, for instance, recently passed new regulations that determine which agricultural PV installations are eligible for funding from a government incentive program with a scope of 1.1 billion euros, giving a boost to innovative agricultural PV installations. While Germany is testing agricultural PV in combination with the cultivation of apples, for example, in Gelsdorf in Rhineland Palatinate, France has started installing solar modules over rows of vines.

With tractor and tracker – trend towards dual use

Covering crops with raised solar modules – as French winegrowers are doing now – is particularly interesting because it is favorable for winegrowing, as well as for fruit, berries or herbs, and any plants that prefer partial shade. Furthermore, solar roofs can replace conventional hail netting or polytunnels, and they protect the crops from drying out.

Integrating solar installations into agriculture opens up many areas of application. Free-standing solar installations on fields and meadows can also be equipped with trackers that follow the course of the sun, which increases the yield compared with conventional, fixed modules, by around 20 percent. The solar panels can also be moved out of the way of any working agricultural machinery.

Agri PV: Hot topic at Intersolar Europe

To learn all there is to know about solar power generation in agriculture, join us at Intersolar Europe. The session “Agricultural PV in France and Germany: Potential, Business Models and Best Practice” (Agri-PV in Deutschland und Frankreich: Potenziale, Geschäftsmodelle und Best Practices) on June 15 at 3:20pm CEST at the Intersolar Forum will be presenting an extensive overview of solutions and applications that already work. An even more hands-on experience will be offered by many exhibitors, such as BayWa r.e. AG, Fraunhofer Institute for Solar Energy Systems (ISE), Next2Sun GmbH, Goldbeck Solar GmbH, SunFarming GmbH and many more. The program of the Intersolar Europe Conference will be looking into agricultural PV one day before the start of the exhibition itself. Experts will be discussing the potential of solar power in agriculture.

Intersolar Europe will be held from June 14–16, 2023 as part of The smarter E Europe 2023 at Messe München. Over 85,000 visitors from all corners of the globe are expected to attend. More than 2,200 exhibitors across 17 exhibition halls covering 180,000 square meters will be waiting for them.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Peggy Zilay
Spokesperson
The smarter E Europe
+49 7231 58598-240
zilay@solarpromotion.com

Juliane Heermeier
Account Manager
+49 151 41482446
juliane.heermeier@fischerappelt.de

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 05:37:00 EET | Press release

Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the National Institute of Standards and Technology (NIST) show that many commercial facial recognition algorithms have significantly higher error rates for women and people of colour largely due to underrepresentation in datasets AI algorithms are trained on. Biased algorithms lead to unfair denials of service and create security vulnerabilities. The competition at the Conference on Neural Information Processing Systems, among the world’s most prestigious AI con

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 01:00:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release

Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye